These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 10213801)

  • 1. Antagonists selective for NMDA receptors containing the NR2B subunit.
    Chenard BL; Menniti FS
    Curr Pharm Des; 1999 May; 5(5):381-404. PubMed ID: 10213801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits.
    Coughenour LL; Barr BM
    J Pharmacol Exp Ther; 2001 Jan; 296(1):150-9. PubMed ID: 11123375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State-dependent NMDA receptor antagonism by Ro 8-4304, a novel NR2B selective, non-competitive, voltage-independent antagonist.
    Kew JN; Trube G; Kemp JA
    Br J Pharmacol; 1998 Feb; 123(3):463-72. PubMed ID: 9504387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ifenprodil, a novel NMDA receptor antagonist: site and mechanism of action.
    Williams K
    Curr Drug Targets; 2001 Sep; 2(3):285-98. PubMed ID: 11554553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes.
    Avenet P; Léonardon J; Besnard F; Graham D; Depoortere H; Scatton B
    Neurosci Lett; 1997 Feb; 223(2):133-6. PubMed ID: 9089691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of NMDA-induced current by the putative NR2B selective antagonist ifenprodil.
    Zhang XX; Bunney BS; Shi WX
    Synapse; 2000 Jul; 37(1):56-63. PubMed ID: 10842351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cleavage of the NR2B subunit amino terminus of N-methyl-D-aspartate (NMDA) receptor by tissue plasminogen activator: identification of the cleavage site and characterization of ifenprodil and glycine affinities on truncated NMDA receptor.
    Ng KS; Leung HW; Wong PT; Low CM
    J Biol Chem; 2012 Jul; 287(30):25520-9. PubMed ID: 22610100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiparkinsonian actions of blockade of NR2B-containing NMDA receptors in the reserpine-treated rat.
    Nash JE; Hill MP; Brotchie JM
    Exp Neurol; 1999 Jan; 155(1):42-8. PubMed ID: 9918703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones.
    Kew JN; Trube G; Kemp JA
    J Physiol; 1996 Dec; 497 ( Pt 3)(Pt 3):761-72. PubMed ID: 9003561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between ifenprodil and the NR2B subunit of the N-methyl-D-aspartate receptor.
    Gallagher MJ; Huang H; Pritchett DB; Lynch DR
    J Biol Chem; 1996 Apr; 271(16):9603-11. PubMed ID: 8621635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites.
    Christie JM; Jane DE; Monaghan DT
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1169-74. PubMed ID: 10688637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genetically modified mouse model probing the selective action of ifenprodil at the N-methyl-D-aspartate type 2B receptor.
    Rosahl TW; Wingrove PB; Hunt V; Fradley RL; Lawrence JM; Heavens RP; Treacey P; Usala M; Macaulay A; Bonnert TP; Whiting PJ; Wafford KA
    Mol Cell Neurosci; 2006 Sep; 33(1):47-56. PubMed ID: 16870468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of extracellular pH on inhibition by ifenprodil at N-methyl-D-aspartate receptors in Xenopus oocytes.
    Pahk AJ; Williams K
    Neurosci Lett; 1997 Mar; 225(1):29-32. PubMed ID: 9143010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
    Williams K
    Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action.
    Kleckner NW; Glazewski JC; Chen CC; Moscrip TD
    J Pharmacol Exp Ther; 1999 May; 289(2):886-94. PubMed ID: 10215667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental changes in NMDA receptor glycine affinity and ifenprodil sensitivity reveal three distinct populations of NMDA receptors in individual rat cortical neurons.
    Kew JN; Richards JG; Mutel V; Kemp JA
    J Neurosci; 1998 Mar; 18(6):1935-43. PubMed ID: 9482779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the binding site of the neuroprotectant ifenprodil on NMDA receptors.
    Perin-Dureau F; Rachline J; Neyton J; Paoletti P
    J Neurosci; 2002 Jul; 22(14):5955-65. PubMed ID: 12122058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on NMDA receptor-mediated EPSCs.
    Barton ME; White HS; Wilcox KS
    Epilepsy Res; 2004 Mar; 59(1):13-24. PubMed ID: 15135163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NR2B selective NMDA antagonists: the evolution of the ifenprodil-type pharmacophore.
    Borza I; Domány G
    Curr Top Med Chem; 2006; 6(7):687-95. PubMed ID: 16719809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.
    Bettini E; Sava A; Griffante C; Carignani C; Buson A; Capelli AM; Negri M; Andreetta F; Senar-Sancho SA; Guiral L; Cardullo F
    J Pharmacol Exp Ther; 2010 Dec; 335(3):636-44. PubMed ID: 20810618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.